1 July 2023 false Taxfiler 2024.5 14936228business:PrivateLimitedCompanyLtd2023-07-012024-06-30 149362282023-06-30 149362282023-07-012024-06-30 14936228business:AuditExemptWithAccountantsReport2023-07-012024-06-30 14936228business:FilletedAccounts2023-07-012024-06-30 149362282024-06-30 14936228business:Director12023-07-012024-06-30 14936228business:RegisteredOffice2023-07-012024-06-30 14936228core:WithinOneYear2024-06-30 14936228countries:EnglandWales2023-07-012024-06-30 14936228business:Micro-entities2023-07-012024-06-30 iso4217:GBP xbrli:pure
Company Registration No. 14936228 (England and Wales)
Luklaw Pharma Ltd Unaudited accounts for the year ended 30 June 2024
Luklaw Pharma Ltd Annual report and unaudited accounts for the year ended 30 June 2024
CONTENTS
PAGE
- 2 -
Luklaw Pharma Ltd Company Information for the year ended 30 June 2024
Director
Lukman Lawal
Company Number
14936228 (England and Wales)
Registered Office
15 Lumley Close Belvedre DAQ17 6NR United Kingdom
Accountants
John Ogunesan FCCA; FFA; ACA Jofetrise Consulting Limited (Accountants & Consultants) 60 Oval Road North, Dagenham Essex RM10 9EL
- 3 -
Luklaw Pharma Ltd Statement of Financial Position as at 30 June 2024
2024 
£ 
Current assets
14,436 
Creditors: amounts falling due within one year
(450)
Net current assets
13,986 
Total assets less current liabilities
13,986 
Net assets
13,986 
Capital and reserves
13,986 
NOTES TO THE ACCOUNTS
1 Statutory information
Luklaw Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14936228. The registered office is 15, Lumley Close, Belvedre, DAQ17 6NR, United Kingdom.
2 Average number of employees
During the year the average number of employees was 1.
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 20 August 2024
Lukman Lawal Director Company Registration No. 14936228
- 4 -